Partnering
- Partnering
From discovery to clinic
seragy works with pharmaceutical, biotechnology and academic partners to develop translational biomarker strategies tailored to their therapeutic programs.
01
Discovery
- Mechanistic characterization
- Target validation
- Biomarker strategy development
02
Preclinical
- Translational biomarker development
- Subtype characterization
- Therapeutic differentiation
03
Clinical
- Patient segmentation approaches
- Disease progression insights
- Biomarker implementation strategies
From pilot studies and fee-for-service projects to long-term co-development partnerships, we work closely with our partners to answer the biomarker questions most relevant to their therapeutic programs.
- Partners
Selected collaborations
